This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
US approves breakthrough CAR T cell cancer therapy
The FDA clears a personalized gene therapy using a patient’s own T cells to attack acute lymphoblastic leukemia. Novartis plans a $475,000 price with potential waivers. centers nationwide will administer the treatment, which may replace some bone marrow transplants. Experts hail a turning point while cautioning about costs and long term efficacy.
MENTIONED IN THIS ARTICLE
Washington
U.S
Food and Drug Administration
Novartis Pharmaceuticals
Stephan Grupp
Children’s Hospital of
Philadelphia
Ted Laetsch
University of Texas Southwestern Medical Center
FDA
Mikhael Sekeres
American Society of Hematology
Sekeres
Cleveland Clinic
Novartis
New Jersey
Grupp
Penn
Carl June
Kite Pharma
National Cancer Institute
Juno Therapeutics
David Maloney
Fred Hutchinson Cancer Research Center
Seattle
Juno
Novartis Pharmaceuticals Corp
Morris Plains
N.J
Emily Whitehead